SavedAdd your journal

Journals / Türk Osteoporoz Dergisi / 2012 / Cilt: 18 - Sayı: 1

HIV and osteoporosis: Three case reports and review of the literature

HIV ve osteoporoz: 3 olgu ve kısa bir derleme

Hamza SUCUOĞLU
Birgül METE
Ülkü AKARIRMAK
Kerem GÜN
Mücahit YEMİŞEN
Murat ULUDAĞ
Pages
27–30
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this case report was to describe clinical findings in three patients we have followed, one with compression fracture and to discuss treatment. (Turkish Journal of Osteoporosis 2012;18:27-30)

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Life expectancy in Human Immunodeficieny Virus (HIV) infection patients has increased as a result of highly active antiretroviral treatment, causing a chronic disease process.
📊
Key Findings & Data:One of these problems is bone loss which was reported to occur frequently in various studies; osteoporosis in 26% and osteopenia in 67% in HIV positive patients.
💡
Conclusion & Impact:The aim of this case report was to describe clinical findings in three patients we have followed, one with compression fracture and to discuss treatment. (Turkish Journal of Osteoporosis 2012;18:27-30)
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Life expectancy in Human Immunodeficieny Virus (HIV) infection patients has increased as a result of highly active antiretroviral treatment, causing a chronic disease process. Treatment agents as well as the longer lasting disease itself seem to bring about new problems. One of these problems is bone loss which was reported to occur frequently in various studies; osteoporosis in 26% and osteopenia in 67% in HIV positive patients. Additional risk factors in these patients were physical inactivity, inadequate nutrition, vitamin D deficiency, low BMI etc. The aim of this case report was to describe clinical findings in three patients we have followed, one with compression fracture and to discuss treatment. (Turkish Journal of Osteoporosis 2012;18:27-30)

Özet

HIV enfeksiyonu olan kişilerde beklenen yaşam süreleri antiretroviral tedavilerin kullanıma girmesi ile anlamlı düzeyde uzamıştır ve bu durum yeni sağlık sorunlarını da beraberinde getirmiştir. Bu sorunlardan biri de kemik mineral yoğunluğunda gelişebilecek kayıplardır. Yapılan çalışmalarda HIV pozitif hastalarda osteoporoz %26 ve osteopeni %67 oranında bildirilmiştir. Bu hastalarda ek risk faktörleri fiziksel hareketsizlik, yetersiz beslenme, D vitamini eksikliği, düşük VKİ'dir. Bu nedenle klinisyenin HIV pozitif hasta takibinde osteoporoz ve ölümle dahi sonuçlanabilecek osteoporotik kırık riskini de göz önünde bulundurması önem arz etmektedir. Bu yazımızda HIV enfeksiyonu ve osteoporoz ilişkisi literatür eşliğinde tartışılarak üç olgu örneği verilmiştir. (Türk Os te opo roz Dergisi 2012;18:27-30)

🔖

Cite This Article

SUCUOĞLU, H., METE, B., AKARIRMAK, Ü., GÜN, K., YEMİŞEN, M., ULUDAĞ, M. (2022). HIV and osteoporosis: Three case reports and review of the literature. Türk Osteoporoz Dergisi, Cilt: 18 - Sayı: 1, 27–30. https://ajindex.com/articles/639919

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Sutinen J, Ristola M. HIV-from a lethal disease to a chronic illness. Duodecim 2012;128:37-46
  2. Brown T, Qaqish R. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS 2006;20:2165-74
  3. Cazanave C, Dupon M, Lavignolle-Aurillac V, Barthe N, Lawson-Ayayi S, Mehsen N, et al. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS 2008;22:395-402
  4. Knobel H, Guelar A, Vallecillo G, Nogués X, Díez A. Osteopenia in HIVinfected patients: is it the disease or is it the treatment? AIDS 2001;15:807-8
  5. Gutierrez F, Masia M. The role of HIV and antiretroviral therapy in bone disease. AİDS Rev 2011;13:109-18
  6. Lima AL, de Oliveira PR, Plapler PG, Marcolino FM, de Souza Meirelles E, Sugawara A, et al. Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. HIV AIDS (Auckl) 2011;3:117-24
  7. Knobel H, Guelar A, Vallecillo G, Nogués X, Díez A. Osteopenia in HIVinfected patients: is it the disease or is it the treatment? AIDS 2001;15:807-8
  8. Bruera D, Luna N, David DO, Bergoglio LM, Zamudio J. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS. 2003;17:1917-23
  9. Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, et al. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. Med Virol 2008;80:1507-14
  10. Cotter EJ, Malizia AP, Chew N, Powderly WG, Doran PP. HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development. AIDS Res Hum Retroviruses 2007;23:1521-30
  11. Fakruddin JM, Laurence J. HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk. J Biol Chem. 2003 Nov 28;278:48251-8. Epub 2003 Sep 15
  12. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397:315-23
  13. Hittinger G, Poggi C, Delbeke E, Profizi N, Lafeuillade A. Correlation between plasma levels of cytokines and HIV-1 RNA copy number in HIV-infected patients. Infection 1998;26:100-3
  14. Aukrust P, Haug CJ, Ueland T, Lien E, Mü